$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Description of the standard dosage and individualized adjustment plan of DaliRasheng (Keweike)
2026-02-01 22:25:32
Check Details
Whether olaparib (lipadro) needs to be taken for life and long-term safety assessment
2026-02-01 22:25:32
Check Details
Long-term maintenance treatment with venetoclax/venetoclax (venetoclax) can last for several years and is safe
2026-02-01 22:25:32
Check Details
Latest information on drug storage and price adjustment for Asnib/Assiminib (Sinbel)
2026-02-01 22:25:32
Check Details
Real evaluation and clinical data analysis of the therapeutic effect of ritexitinib (Lefenox)
2026-02-01 22:25:32
Check Details
Treprostinil Dry Powder Inhaler (treprostinil)-Yutrepia is a medicine that treats what
2026-02-01 22:25:32
Check Details
AGILE: Long-term outcomes of ivonib versus placebo in newly diagnosed acute myeloid leukemia with IDH1 mutations
2026-02-01 22:25:32
Check Details
How the price of Mitotane compares to other drugs
2026-02-01 22:25:32
Check Details
Bevacizumab plus erlotinib highly effective in HLRCC-related papillary renal cell carcinoma
2026-02-01 22:25:32
Check Details
The efficacy of tofacitinib/Shangjie in the treatment of rheumatoid arthritis
2026-02-01 22:25:32
Check Details
Does cycloserine have any effect on creatinine levels?
2026-02-01 22:25:32
Check Details
What is the relationship between Linezolid and Sivo?
2026-02-01 22:25:32
Check Details
1
2
...
2195
2196
2197
2198
2199
2200
2201
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma